SCHEMBL6907211

SCHEMBL6907211

Cc1cccc(C)c1-c1cnc(N)nc1-c1c(-c2ccc(F)cc2)ncn1C1CCNCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 18/20 0.61
MAPK11 Q15759 4/20 0.61
MAPK13 O15264 2/20 0.61
MAPK12 P53778 2/20 0.61
PRKD3 O94806 2/20 0.61
MAP4K4 O95819 2/20 0.61
PRKACA P17612 2/20 0.61
CSNK1A1 P48729 2/20 0.61
CSNK1D P48730 2/20 0.61
MINK1 Q8N4C8 2/20 0.61
MAP4K5 Q9Y4K4 2/20 0.61
RIPK2 O43353 1/20 0.61
DYRK3 O43781 1/20 0.61
PRKCG P05129 1/20 0.61
LCK P06239 1/20 0.61
LYN P07948 1/20 0.61
RET P07949 1/20 0.61
PIM1 P11309 1/20 0.61
MAPK1 P28482 1/20 0.61
FLT4 P35916 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7058352 0.88 MAPK14 (0.60) MAPK14MAPK11MAPK13MAPK12PRKD3
SCHEMBL7688265 0.87 MAPK14 (0.45) MAPK14MAPK11MAPK13MAPK12PRKD3
SCHEMBL6907208 0.83 MAPK14 (0.57) MAPK14MAPK11MAPK13MAPK12PRKD3
SCHEMBL13819564 0.80 MAPK14 (0.74) MAPK14MAPK11MAPK13MAPK12PRKD3
SCHEMBL7058351 0.76 MAPK14 (0.55) MAPK14MAPK11MAPK13MAPK12PRKD3
Sb-220025 SCHEMBL173441 0.76 MAPK14 (1.00) MAPK14MAPK11MAPK13MAPK12PRKD3
Sb-220025 SCHEMBL18066291 0.75 MAPK14 (0.98) MAPK14MAPK11MAPK13MAPK12PRKD3
SCHEMBL6946413 0.75 MAPK14 (1.00) MAPK14MAPK11PRKD3MAP4K4PRKACA
SCHEMBL4920875 0.73 MAPK14 (0.71) MAPK14MAPK11MAPK13MAPK12PRKD3
SCHEMBL6948107 0.73 MAPK14 (1.00) MAPK14MAPK11PRKD3MAP4K4PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730683-B2 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses SMITHKLINE BEECHAM CORPORATION 2004-05-04 US disclosed
US-20020198206-A1 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses SMITHKLINE BEECHAM CORPORATION 2002-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020198206-A1 Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses IL2, IFNG, IL2RA MAPK14 1513/4885MAPK11 1423/4885MAPK13 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.